Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-23T16:53:47.916Z Has data issue: false hasContentIssue false
  • English
  • Français

Percutaneous pulmonary and aortic valve insertion in Belgium: Going for conditional reimbursement or waiting for further evidence?

Published online by Cambridge University Press:  21 July 2009

Mattias Neyt ,
Imgard Vinck ,
Marc Gewillig  and
Hans Van Brabandt
Mattias Neyt
Affiliation:
Belgian Health Care Knowledge Centre
Imgard Vinck
Affiliation:
Belgian Health Care Knowledge Centre
Marc Gewillig
Affiliation:
University Hospital Gasthuisberg
Hans Van Brabandt
Affiliation:
Belgian Health Care Knowledge Centre
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives: The aim of this study was to assess current evidence supporting the use of percutaneous heart valves (PHV) in degenerative aortic valve and congenital pulmonary outflow tract disease, as compared to conservative medical therapy or traditional surgical valve replacement.

Methods: A systematic review of the literature on PHV was performed.

Results: No randomized controlled trials (RCT) on PHV have been published so far. Only observational data from series and data presented at cardiology meetings are available. Both percutaneous aortic valve (PAV) and percutaneous pulmonary valve (PPV) seem feasible in the hands of an experienced team. Safety, however, seems to be a problem in PAV, as shown by the high 30-day and 6-month mortality rates.

Conclusions: Due to safety concerns, PAV reimbursement is not recommended and patients should only be subjected to PAV insertion within the boundaries of an RCT. In contrast, PPV implantation seems to be a safe and promising technology for which reimbursement under strict conditions may be recommended.

Keywords

Heart valve prosthesisHeart valve prosthesis implantationTechnology assessmentBiomedical
Type
General Essays
Information
International Journal of Technology Assessment in Health Care , Volume 25 , Issue 3 , July 2009 , pp. 281 - 289
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Antunes, MJ. Off-pump aortic valve replacement with catheter-mounted valved stents. Is the future already here? Eur J Cardiothorac Surg. 2007;31:1–3.CrossRefGoogle Scholar
2. Antunes, MJ. Percutaneous aortic valve implantation. The demise of classical aortic valve replacement? Eur Heart J. 2008;29:1339–1341.Google Scholar
3. Berry, C, Asgar, A, Lamarche, Y, et al. Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving System. Catheter Cardiovasc Interv. 2007;70:610–616.CrossRefGoogle ScholarPubMed
4. Bonhoeffer, P, Boudjemline, Y, Saliba, Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403–1405.CrossRefGoogle Scholar
5. Bridgewater, B, Keogh, B. Surgical “league tables”: Ischaemic heart disease. Heart. 2008;94:936–942.Google Scholar
6. Brown, ML, Schaff, HV, Sarano, ME, et al. Is the European System for Cardiac Operative Risk Evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement? J Thorac Cardiovasc Surg. 2008;136:566–571.CrossRefGoogle ScholarPubMed
7. Chandavimol, M, McClure, SJ, Carere, RG, et al. Percutaneous aortic valve implantation: A case report. Can J Cardiol. 2006;22:1159–1161.CrossRefGoogle ScholarPubMed
8. Cribier, A, Eltchaninoff, H, Bash, A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: First human case description. Circulation. 2002;106:3006–3008.Google Scholar
9. Cribier, A, Eltchaninoff, H, Tron, C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004;43:698–703.CrossRefGoogle ScholarPubMed
10. Cribier, A, Eltchaninoff, H, Tron, C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: Mid-term follow-up from the initial feasibility studies: The French experience. J Am Coll Cardiol. 2006;47:1214–1223.CrossRefGoogle ScholarPubMed
11. Descoutures, F, Himbert, D, Lepage, L, et al. Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly. Eur Heart J. 2008;29:1410–1417.CrossRefGoogle ScholarPubMed
12. Dewey, TM, Brown, D, Ryan, WH, et al. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg. 2008;135:180–187.CrossRefGoogle ScholarPubMed
13. Eltchaninoff, H, Tron, C, Bauer, F, et al. Aortic bioprosthesis implanted percutaneously: Three year follow up. Arch Mal Coeur Vaiss. 2007;100:901, 904–908.Google Scholar
14. European Parliament and the Council of the European Union. Directive 2007/47/EC of the European Parliament and of the Council of 5 September 2007 amending Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices, Council Directive 93/42/EEC concerning medical devices and Directive 98/8/EC concerning the placing of biocidal products on the market, Official Journal of the European Union, L 247/21, 21 September 2007.Google Scholar
15. Grube, E, Laborde, JC, Gerckens, U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg first-in-man study. Circulation. 2006;114:1616–1624.Google Scholar
16. Grube, E, Schuler, G, Buellesfeld, L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: Device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69–76.CrossRefGoogle ScholarPubMed
17. Haute Autorité de Santé (HAS). Évaluation des bioprothèses valvulaires aortiques implantées par voie rétrograde transfémorale et transapicale. Paris: HAS; 2008 (janvier).Google Scholar
18. Khambadkone, S, Coats, L, Taylor, A, et al. Percutaneous pulmonary valve implantation in humans: Results in 59 consecutive patients. Circulation. 2005;112:1189–1197.CrossRefGoogle ScholarPubMed
19. Lichtenstein, SV, Cheung, A, Ye, J, et al. Transapical transcatheter aortic valve implantation in humans: Initial clinical experience. Circulation. 2006;114:591–596.Google Scholar
20. Ludwig Boltzmann Institut für Health Technology Assessment (LBI-HTA). Perkutan implantierbare Pulmonalklappen bei angeborenen Herzfehlern des rechtsventrikul ren Ausflusstraktes: Systematischer Review. Decision Support Document Nr. 10; 2008 (März).Google Scholar
21. Lurz, P, Coats, L, Khambadkone, S, et al. Percutaneous pulmonary valve implantation: Impact of evolving technology and learning curve on clinical outcome. Circulation. 2008;117:1964–1972.Google Scholar
22. Marcheix, B, Lamarche, Y, Berry, C, et al. Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis. J Thorac Cardiovasc Surg. 2007;134:1150–1156.CrossRefGoogle ScholarPubMed
23. NICE. Interventional procedure overview of percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction. Interventional procedures programme. London: National Institute for Health and Clinical Excellence; 2007.Google Scholar
24. NICE. Catheter insertion of a new aortic valve to treat aortic stenosis. London: National Institute for Health and Clinical Excellence; 2008.Google Scholar
25. Sack, S, Naber, C, Kahlert, P, et al. Percutaneous heart valve implantation in the aortic position. Herz. 2005;30:433–437.CrossRefGoogle ScholarPubMed
26. Serruys, PW. Transcatheter aortic valve implantation: A state-of-the-art. Barcelona, Spain: EuroPCRonline.com; 2008.Google Scholar
27. Svensson, LG, Dewey, T, Kapadia, S, et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg. 2008;86:46–54; discussion 54–55.Google Scholar
28. US Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health. Guidance for Industry and FDA Staff—Humanitarian Device Exemption (HDE) Regulation: Questions and Answers. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration.Google Scholar
29. Vahanian, A, Alfieri, O, Al-Attar, N, et al. Transcatheter valve implantation for patients with aortic stenosis: A position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2008;29:1463–1470.CrossRefGoogle Scholar
30. Van Brabandt, H, Neyt, M. Percutaneous heart valve implantation in congenital and degenerative valve disease. A rapid Health Technology Assessment. KCE reports. Brussels: Belgian Health Care Knowledge Centre (KCE); 2008.Google Scholar
31. Vinck, I, Neyt, M, Thiry, N, et al. A framework for the assessment of emerging medical devices. KCE reports. Brussels: Belgium Health Care Knowledge Centre (KCE); 2006.Google Scholar
32. Vinck, I, Neyt, M, Thiry, N, Louagie, M, Ramaekers, D. Introduction of emerging medical devices on the market: A new procedure in Belgium. Int J Technol Assess Health Care. 2007;23:449–454.CrossRefGoogle Scholar
33. Walther, T, Simon, P, Dewey, T, et al. Transapical minimally invasive aortic valve implantation: Multicenter experience. Circulation. 2007;116 (Suppl):I240-I245.CrossRefGoogle ScholarPubMed
34. Walther, T, Falk, V, Borger, MA, et al. Minimally invasive transapical beating heart aortic valve implantation–proof of concept. Eur J Cardiothorac Surg. 2007;31:9–15.CrossRefGoogle ScholarPubMed
35. Walther, T, Falk, V, Kempfert, J, et al. Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur J Cardiothorac Surg. 2008;33:983–988.CrossRefGoogle ScholarPubMed
36. Webb, JG, Chandavimol, M, Thompson, CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation. 2006;113:842–850.Google Scholar
37. Webb, JG, Pasupati, S, Humphries, K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755–763.CrossRefGoogle ScholarPubMed
38. Wild, C, Langley, T, Gartlehner, G. Minimal-invasiver perkutaner Aortenklappenersatz. Wien: Institut fur Health Technology Assessment der Ludwig Boltzmann-Gesellschaft; 2008.Google Scholar
39. Ye, J, Cheung, A, Lichtenstein, SV, et al. Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. Eur J Cardiothorac Surg. 2007;31:16–21.CrossRefGoogle ScholarPubMed
40. Zuckerman, B, Sapirstein, W, Swain, JA. The FDA role in the development of percutaneous heart valve development. Eurointervention. 2006;1:A75–A78.Google Scholar